Patient Reported Outcome Measures
"Patient Reported Outcome Measures" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Assessment of the quality and effectiveness of health care as measured and directly reported by the patient.
| Descriptor ID |
D000071066
|
| MeSH Number(s) |
E05.318.308.980.344.500 N03.349.380.210.750 N04.761.559.590.399.875 N05.425.210.500 N05.715.360.300.800.344.500 N05.715.360.575.575.399.875 N06.850.520.308.980.344.500
|
| Concept/Terms |
Patient Reported Outcomes- Patient Reported Outcomes
- Outcome, Patient Reported
- Outcomes, Patient Reported
- Reported Outcome, Patient
- Reported Outcomes, Patient
- Patient Reported Outcome
|
Below are MeSH descriptors whose meaning is more general than "Patient Reported Outcome Measures".
Below are MeSH descriptors whose meaning is more specific than "Patient Reported Outcome Measures".
This graph shows the total number of publications written about "Patient Reported Outcome Measures" by people in this website by year, and whether "Patient Reported Outcome Measures" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 0 | 2 |
| 2017 | 36 | 36 | 72 |
| 2018 | 39 | 34 | 73 |
| 2019 | 12 | 14 | 26 |
| 2020 | 5 | 9 | 14 |
| 2021 | 0 | 7 | 7 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Patient Reported Outcome Measures" by people in Profiles.
-
Development and Validation of the Long Coronavirus Disease (COVID) Symptom and Impact Tools: A Set of Patient-Reported Instruments Constructed From Patients' Lived Experience. Clin Infect Dis. 2022 01 29; 74(2):278-287.
-
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis. Rheumatology (Oxford). 2021 10 09; 60(SI):SI3-SI12.
-
Digital disparities: lessons learned from a patient reported outcomes program during the COVID-19 pandemic. J Am Med Inform Assoc. 2021 09 18; 28(10):2265-2268.
-
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int. 2021 Nov; 41(11):1925-1931.
-
Postintensive Care Syndrome in Survivors of Critical Illness Related to Coronavirus Disease 2019: Cohort Study From a New York City Critical Care Recovery Clinic. Crit Care Med. 2021 09 01; 49(9):1427-1438.
-
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma. Br J Haematol. 2022 01; 196(1):95-98.
-
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases. Mult Scler Relat Disord. 2021 Oct; 55:103189.
-
Proceedings Report of the Fifth Symposium on Hidradenitis Suppurativa Advances (SHSA) 2020. J Drugs Dermatol. 2021 Aug 01; 20(8):868-873.
-
The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort. Cancer. 2021 11 01; 127(21):4072-4080.
-
Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort. Lupus. 2021 Oct; 30(11):1747-1755.